The Complete Guide to Preventative Health, Longevity & Biomarker Optimisation

Healthcare in the UK has traditionally followed a reactive model: you develop a symptom, you see a GP, and a treatment is prescribed. This approach is invaluable when something goes wrong, but it leaves a significant gap when it comes to keeping already healthy people healthy.

Preventative healthcare closes that gap. Rather than waiting for disease to declare itself, preventative medicine uses detailed physiological data — particularly blood biomarkers — to identify patterns of decline years, sometimes decades, before clinical illness develops. The aim is not simply to avoid disease but to optimise the way your body functions right now.

Private blood testing offers something the overstretched NHS system cannot routinely provide: a deep, comprehensive snapshot of your health across multiple organ systems, interpreted not against a threshold of “not yet ill” but against the standard of genuine physiological good health.

A biomarker is a measurable biological indicator — a substance found in your blood, urine, or tissue — that reflects what is happening inside a specific system of your body (e.g. liver, kidney, thyroid). When interpreted together, a panel of biomarkers creates a detailed picture of your overall health that no single test can provide alone.

A comprehensive private health check typically begins with a Full Blood Count (FBC) as the base (common in most of our large panels), which assesses:

• Red blood cell health — oxygen delivery and potential anaemia
• White blood cell count — immune system function and hidden infection
• Platelets — clotting ability and bleeding risk

From this foundation, advanced panels extend into cardiovascular, metabolic, hormonal, nutritional, and inflammatory markers — each revealing a different dimension of how well your body is functioning and ageing.

View all tests→

Your chronological age is simply the number of years since you were born. Your biological age is a more meaningful measure — it reflects how old your cells, organs, and tissues actually function, regardless of the year you were born.

Two people who are both 50 years old can have massively different biological ages. One might have the cardiovascular system of a 40-year-old; the other, the metabolic function of a 65-year-old. The difference comes down to genetics, lifestyle, diet, sleep, stress, and how early and consistently they have monitored and acted on their health data.

Advances in medical imaging (like CT scans and MRI, for example) and blood analysis now allow clinicians to estimate biological age from physiological data alone. Research (Pickhardt et al., 2025) demonstrated that automated cardiometabolic biomarkers derived from CT imaging could accurately predict phenotypic longevity — showing that biological ageing is measurable and modifiable.

By tracking your biomarkers over time and making evidence-based lifestyle adjustments, you can measurably slow the rate at which your body ages biologically.

Cardiovascular disease remains one of the leading causes of death in the UK, yet the majority of cases are preventable with early detection and intervention. The key is knowing which markers to look at and understanding what they actually tell you.

Standard cholesterol testing: a good start, but not enough

A routine cholesterol test measures your total cholesterol, HDL (“good” cholesterol), and LDL (“bad” cholesterol). While useful, this picture could do with a little more. Standard LDL measurement is a calculated estimate, and in a significant proportion of people, it underestimates true cardiovascular risk.

Apolipoprotein B (ApoB): the gold standard for cardiovascular risk

ApoB is the protein that coats every atherogenic (artery-hardening) particle in your blood — including LDL, VLDL, and lipoprotein(a). Unlike LDL, which measures the concentration of cholesterol, ApoB counts the number of harmful particles. Since each particle carries exactly one ApoB molecule, ApoB gives an exact count of how many potentially dangerous particles are circulating in your bloodstream.

In a fantastic systematic review, researchers (Sehayek et al., 2025) analysed data from more than 500,000 individuals and concluded that ApoB is a more accurate predictor of cardiovascular risk than either LDL cholesterol or non-HDL cholesterol, particularly in people with metabolic syndrome, diabetes, or high triglycerides. This has been reinforced by an updated analysis published in 2024.

Additional cardiovascular markers worth measuring

Explore our advanced cholesterol panel→

Insulin resistance and dysregulated blood sugar are among the most widespread yet underdiagnosed health issues in the UK. They lie at the root of type 2 diabetes, non-alcoholic fatty liver disease, polycystic ovary syndrome (PCOS), and much of the cardiovascular disease burden. They develop slowly, asymptomatically (no signs and/or symptoms), over years.

HbA1c: your three-month blood sugar average

The HbA1c test (glycated haemoglobin) is the most reliable method for assessing long-term blood sugar control. When blood glucose is elevated, it binds irreversibly to haemoglobin in your red blood cells, forming HbA1c. Because red blood cells survive for approximately 90 days, the HbA1c value provides a precise rolling average of your blood glucose over the preceding three months — far more meaningful than a single fasting glucose reading.

UK clinical reference ranges (NICE, 2022):

National Institute for Health and Care Excellence (2022) guidelines recommend HbA1c testing as the primary diagnostic criterion for type 2 diabetes in adults.

Fasting insulin and HOMA-IR

For an even earlier window into metabolic dysfunction, fasting insulin — combined with fasting glucose to calculate the HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) score — can reveal insulin resistance years before HbA1c becomes abnormal. This is rarely tested in standard NHS care but is super useful for proactive metabolic health assessment.

Explore our Metabolic Health Panel→

Inflammation is one of the body's most essential defence mechanisms. When you sustain an injury or encounter an infection, your immune system triggers an acute inflammatory response to contain the threat and begin the healing process. This is entirely healthy and necessary.

The problem arises when this response never fully switches off. Chronic low-grade inflammation — sustained, systemic, and often entirely symptom-free — is now recognised as a central mechanism driving ageing itself, as well as many of the conditions most likely to shorten your life: cardiovascular disease, type 2 diabetes, neurodegenerative disorders, and certain cancers, for example.

High-sensitivity C-Reactive Protein (hs-CRP)

hs-CRP is produced by the liver in response to inflammation signals from throughout the body. The high-sensitivity version of the test can detect very low levels of CRP that a standard test would miss — making it ideal for identifying subclinical (pre-symptomatic) chronic inflammation.

The clinical evidence is compelling. Researchers (Liu et al., 2025) conducted a retrospective cohort study and found that patients with elevated hs-CRP levels faced nearly twice the all-cause mortality risk compared to those with low levels — even after adjusting for other confounding factors. Crucially, hs-CRP levels are modifiable through lifestyle intervention.

What drives chronic inflammation?

• Processed and ultra-processed foods (particularly refined sugars and vegetable oils)
• Physical inactivity and obesity, particularly visceral (abdominal) fat
• Poor sleep quality and chronic psychological stress
• Smoking and excessive alcohol consumption
• Undiagnosed gut dysbiosis or food sensitivities

The practical benefit of measuring hs-CRP is that it gives you objective feedback. If dietary and lifestyle changes are working, your hs-CRP will fall and you will have data to prove it.

Nutritional deficiencies are remarkably common across the UK population, yet most people remain completely unaware of them. Standard NHS blood tests do not routinely include a comprehensive nutritional panel. The symptoms of deficiency — fatigue, low mood, brain fog, reduced immunity, for example — are frequently attributed to stress, ageing, or simply feeling run down.

A targeted private blood test removes the guesswork.

Vitamin D (25-OH Vitamin D)

Vitamin D is far more than a “bone vitamin.” It also functions as a steroid hormone involved in immune regulation, mood, cardiovascular function, and anti-inflammatory pathways. The UK's climate and culture (indoor work, sun avoidance) mean deficiency is endemic, particularly outside the summer months.

Public Health England estimates that approximately 1 in 5 UK adults have low vitamin D levels.

• DeficientBelow 25 nmol/L
• Insufficient25–50 nmol/L
• Optimal75–150 nmol/L (functional medicine range)

Active B12 and folate

Standard B12 tests measure total B12 in the blood, including a large fraction bound to proteins meaning they are biologically unavailable. Active B12 (holotranscobalamin) measures only the fraction your cells can actually use, giving a far more accurate picture of your true B12 status.

Folate works alongside B12 in DNA synthesis and homocysteine metabolism. Deficiency in either is often associated with fatigue, cognitive decline, mood disturbance, and in pregnancy, serious neural tube defects.

Ferritin: the true marker of iron status

Serum iron and haemoglobin can appear normal even when iron stores are critically depleted. Ferritin is the storage protein for iron and is the most sensitive early indicator of iron deficiency. Low ferritin — even without clinical anaemia — is one of the most common, correctable, and overlooked causes of persistent fatigue, particularly in women of reproductive age.

Magnesium (red cell)

Standard serum magnesium tests are notoriously poor at detecting cellular magnesium deficiency, because the body tightly regulates serum levels even as intracellular stores fall. Red cell magnesium provides a more accurate assessment of your actual magnesium status — important given that magnesium is involved in over 300 enzymatic processes, including energy production, nerve function, and sleep regulation.

Explore our diet and lifestyle panel→

This is one of the most important distinctions in preventative medicine — and one that most people never consider.

“Normal” ranges on a standard blood test are calculated statistically: they represent the middle 95% of results from the population that was tested. By definition, 5% of perfectly healthy people will fall outside the “normal” range, and someone with progressive metabolic dysfunction may sit comfortably within it.

“Optimal” ranges are derived differently. They are based on large-scale longitudinal research examining which biomarker values correlate with the lowest rates of disease and the longest, healthiest lives. Optimal ranges ask: “What does this marker look like in people who are genuinely thriving?”

Let's consider HbA1c: a result of 47 mmol/mol sits just inside the “normal” NHS range (below 48 mmol/mol) and would not prompt any clinical action. Yet from a longevity perspective, this represents the very threshold of prediabetes. This could mean significant physiological damage may already be accumulating.

The goal of biomarker optimisation is not to avoid red flags. It is to live in the green zone.

A single blood test is a snapshot. A series of blood tests, taken regularly over time, is a film — and it tells a far richer story.

Biomarker tracking allows you to:

• Establish your personal baseline — understanding where you start is the essential first step
• Measure the impact of lifestyle interventions — whether you change your diet, begin a new exercise protocol, adjust supplementation, or improve sleep, your biomarkers will reflect the change objectively
• Catch negative trends early — a gradual rise in ApoB or fasting insulin over two years is far easier to reverse than an established cardiovascular event or diabetes diagnosis
• Quantify your rate of biological ageing, and work to decelerate it with evidence-based interventions

(Pickhardt et al., 2025) demonstrated in their research that biological age can be accurately predicted from measurable cardiometabolic biomarkers, validating the principle that ageing is not simply inevitable — it is, to a meaningful degree, also manageable.

Most people who commit to regular biomarker tracking make tangible improvements to their results within 6–12 months of their first comprehensive test, simply by having clear, personalised data to act on.

Straight answers to the questions we hear most often about preventative testing and biomarker optimisation.

We used the following resources to create this article:

1. Liu, T., Xu, G. G., Chen, B., Zeng, K. J., Weng, Y., Li, P., . . . Chen, P. C. (2025). High-sensitivity C-reactive protein and all-cause mortality in patients with diabetic foot and osteoporosis: Evidence from a retrospective cohort study. Frontiers in Medicine, 12, Article 1700752. doi.org/10.3389/fmed.2025.1700752
2. National Institute for Health and Care Excellence. (2022). Type 2 diabetes in adults: Management (NICE Guideline NG28, updated 2022). NICE. www.nice.org.uk/guidance/ng28
3. Sehayek, D., Cole, J., Björnson, E., Wilkins, J. T., Mortensen, M. B., Dufresne, L., Pencina, K. M., Pencina, M. J., Thanassoulis, G., & Sniderman, A. D. (2025). ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. Journal of clinical lipidology, 19(4), 844–859. doi.org/10.1016/j.jacl.2025.05.024
4. Pickhardt, P.J., Kattan, M.W., Lee, M.H. et al. (2025). Biological age model using explainable automated CT-based cardiometabolic biomarkers for phenotypic prediction of longevity. Nat Commun 16, 1432. doi.org/10.1038/s41467-025-56741-w